NEJM names new editor-in-chief |
CV stents market expected to exceed $13B by 2025 |
UTIs linked to 5 times the risk of ischemic stroke |
FDA fast-tracks empagliflozin for treatment of chronic HF |
Under Armour files patent application for BP-monitoring sneakers |
Statins linked to double the risk of type 2 diabetes |
Magnitude of industry payments to CV lab directors of great concern |
San Francisco becomes 1st US city to ban e-cig sales |
AHA awards $14M in grants to study arrhythmias, cardiac arrest |
Sanofi cuts 466 jobs, all ties to new CV research |
ACC: 1 in 4 cardiologists are burned out |
CMS finalizes coverage guidelines for TAVR |
E-tattoo combines ECG, SCG capabilities to track heart health |
Joint Commission, AHA offer new accreditations for MI centers |
Testing underway for biodegradable CV implants |
FDA reaches vague conclusion in debate over safety of paclitaxel devices |
TCT, VEITHsymposium partner to strengthen conference material |
Philips updates, expands cardiac ultrasound platform |
Nevada cardiology practice shells out $2.5M to settle Medicare kickback claims |
Jane Freedman named new editor of Circulation Research |
The best hospitals for pediatric cardiology and heart surgery in the US |
Cognitive function may deteriorate faster after MI, angina |
Robotic catheter paves the way for combo valve procedures |
Experimental tool leverages smart speaker tech to detect cardiac arrest |
The average person is just 4 degrees of separation from heart failure |
Online pharmacy IDs 4th carcinogen in a BP drug |
FDA clears CV planning software suite from Materialise |
Poor fruit, vegetable intake responsible for millions of CV deaths |
UNC Children’s suspends complex heart surgeries amid investigation |
BP drug nilvadipine could benefit Alzheimer’s patients |
Are Americans prone to heart attack during vacation? |
Sauna visits affect BP, heart rate like moderate exercise |
Wealth, debt and spending: How cardiologists manage their money in 2019 |
Cardiologist found guilty of billing insurers $13M for needless angina treatments |
Transcarotid access: The future of non-femoral TAVR? |
Why the next TAVR vs. SAVR trial should be in bicuspid AS patients |
‘Our patients are worth it’: Tackling the undertreatment of aortic stenosis in the US |
Bacterial enzyme converts type A blood to universal type O |
Is synthetic apelin the insulin of heart disease? |
ARB recalls resurface as Teva pulls 6 lots of losartan from market |
Eli Lilly stocks down, Novo Nordisk stocks up after REWIND data goes public |
ACC, Veradigm partner to create largest ambulatory chronic disease network in the US |
Undetected diabetes could lead to MI, gum disease |
3 interventions could prevent 94M early deaths by 2040 |
Patients with untreated white coat hypertension twice as likely to die of CVD |
Study predicts 14M older Europeans will have AFib by 2060 |
TECAB reduces risk, expedites recovery for bypass patients |
Stent strut thickness after PCI: Is thinner always better? |
Valve-in-valve TAVR proves successful in the long-term |
Teen’s birth control triggers stroke |
Red, white meats equally detrimental to blood cholesterol |
5 ways to tackle mental health after a heart attack |
Latest analysis of evolocumab suggests the drug is—finally—affordable |
US soldiers have poorer heart health than civilians |
TAVR outcomes worse in patients with end-stage renal disease |
FDA issues warning to stem cell company promoting unapproved stroke therapies |
ICU admission yields better results for STEMI patients—at a price |
Biotronik targets women in study of ICD outcomes |
Beta-blockers mitigate emotionally triggered AFib |
CDC reports longest-ever decline in new diabetes cases |
Stem cell patches rejuvenate damaged heart muscle after MI |
Heart patient gifts Loyola cardiology $1.5M |
The ‘weekend effect’ doesn’t apply to victims of cardiac arrest |
Trouble at UNC: State launches investigation into pediatric heart surgery program |
HF patients less likely to follow treatment advice if they’re lonely |